Updated · 1 episodes · 1 show · 1 source notes

entity

Robert Malenka

Overview

Robert Malenka is a psychiatrist and neuroscientist presented in the source as a Stanford professor whose research connects synaptic plasticity, reward circuitry, addiction, social behavior, empathy-like assays, autism models, and the use of psychoactive compounds as mechanistic probes.

Current Profile

In How Your Brain’s Reward Circuits Drive Your Choices | Dr. Robert Malenka, Malenka resists popular one-molecule explanations. He describes dopamine as one context-sensitive neuromodulator within circuits that integrate memory, emotion, planning, sensation, and body state; treats addiction as durable reinforcement learning and synaptic change rather than pleasure alone; and presents social interaction as an adaptive reward shaped by dopamine, serotonin, and oxytocin together.

His translational approach is cautious. Mouse tasks can isolate antecedents of empathy without reproducing the human phenomenon, autism findings require subgroup logic, and MDMA or psychedelics can serve as powerful research probes without becoming universal treatments. He also discloses involvement with MapLight Therapeutics and MindMed in the episode, making institutional interests part of the interpretation boundary.

Key Characteristics

  • Links molecular and synaptic plasticity to circuit-level behavior and psychiatric questions.
  • Distinguishes dopamine-mediated salience and reinforcement from pleasure alone.
  • Studies addiction as learned and persistent remodeling of reward-related circuits.
  • Uses animal assays to decompose sociability, pain transfer, social analgesia, generosity, and harm prevention.
  • Treats autism as heterogeneous and resists blanket claims about social motivation or empathy.
  • Uses psychoactive drugs as experimentally tractable probes while emphasizing legal, ethical, and clinical limits.

Evidence

Qualifications

This profile is grounded in one condensed episode summary rather than a complete publication record. Claims about priority, mechanisms, receptor specificity, animal-to-human translation, company trials, or therapeutic efficacy remain source-scoped. Disclosed commercial or advisory relationships do not invalidate the research discussion, but they are relevant context for interpreting development claims.

What Changed

  • Created a profile joining Malenka’s neuroplasticity, addiction, social-neuroscience, and translational-research roles.

Relationships

Sources

1 source notes across 1 show
  1. How Your Brain’s Reward Circuits Drive Your Choices | Dr. Robert Malenka Huberman Lab